APOTEEK JACOBS
ActiveSummary
APOTEEK JACOBS has been active since 1995 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €200,991 and a net result of €105,565. Equity has been stable since 2018 (±2.5% per year). Its solvency ranks better than 65% of 22,774 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 25-01-1995 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committees
- 330 Paritair Comité voor de gezondheidsinrichtingen en -diensten
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2023
- Establishment unit
- 2.071.203.782 2520 Ranst, since 14-04-1995
- Financial year end
- 31 December
- Peppol
- Reachable since 08-05-2025
Board and ownership
- Marc Van De MieroopDirector
- LUPIO100%· score 932025 annual accounts of LUPIO
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €210,359
- ▼ 12.9%
- Turnover
- ≈ €660,000
- estimated
- Profit
- €105,565
- ▲ 21.8%
- Equity
- €200,991
- ▲ 0.3%
- Total assets
- €402,651
- ▲ 6.9%
- Employees on 31-12-2025
- 0
- ▼ 100%
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.62, cash €80,969Founded in 1995Equity €200,991 (49.9% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 64% of them on solvency, 54% on liquidity, 96% on profitability and 40% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 59 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Higher net result than 95% of companies in retail tradesector median €5,083 · 22,756 companies €105,565 View
- Caution: Board changedlatest change 01-10-2026 · 1 in office 1 joined · 1 left View
- Positive: 8 profitable years in a rowprofit 2025: €105,565 8 years View
- Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View
Recent changes
- · Gazette deed Appointment: Marc Van De Mieroop (director)Resignation: Katrien Piot (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTEEK JACOBS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €388,000 and €449,000, founded between 1992 and 1999.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTEEK JACOBS Ranst | €402,651 | €210,359 |
| APOTHEEK DELANG - GOOSSENS Sint-Katelijne-Waver | €408,318 | €196,695 |
| APOTHEEK MUTSAERD Brussel | €431,360 | €203,634 |
| VERTONGEN-DE MUNCK Dendermonde | €405,677 | €231,498 |
| RINGFARMA Grimbergen | €449,367 | €207,636 |
| APOTHEEK DRIE FONTEINEN Tervuren | €387,846 | €236,609 |
| Apotheek G. Dezillie Duffel | €402,574 | €227,580 |
Key facts about APOTEEK JACOBS
- What is the company number of APOTEEK JACOBS?
- The company number of APOTEEK JACOBS is 0454.398.775. The VAT number is the same number with BE in front: BE 0454.398.775.
- Where is APOTEEK JACOBS based?
- The registered office is at Lievevrouwestraat 36, 2520 Ranst.Company details
- What does APOTEEK JACOBS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTEEK JACOBS?
- The legal form of APOTEEK JACOBS is Public limited company (NV).
- When was APOTEEK JACOBS founded?
- APOTEEK JACOBS was founded on 25-01-1995.
- Is APOTEEK JACOBS still active?
- Yes, APOTEEK JACOBS is an active enterprise in the KBO register.
- How many employees does APOTEEK JACOBS have?
- APOTEEK JACOBS had an average of 0.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTEEK JACOBS fall under?
- In its 2023 annual accounts, APOTEEK JACOBS states joint committees 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten) and 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTEEK JACOBS?
- The turnover in financial year 2025 is ≈ €660,000. This figure is estimated from the gross margin of €210,359 and 32 comparable companies (NACE 477). It probably lies between €460,000 and €1.3m.
- Is APOTEEK JACOBS profitable?
- In financial year 2025, APOTEEK JACOBS made a profit of €105,565.
- Where can I find the annual accounts of APOTEEK JACOBS?
- APOTEEK JACOBS filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTEEK JACOBS due?
- APOTEEK JACOBS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.